FIELD: hematology. SUBSTANCE: test sample of blood is placed in solution of protamine sulfate in veronal buffer. Incubation leads to formation of blood clot, which is removed, after which optical densities of resulting hemolysate and reference blood sample are measured. Plasmin fibrinolytic activity is determined from ratio of optical density of hemolysate to that of reference blood sample. The latter contains the same amount of protamine sulfate solution, which was not subjected to incubation. EFFECT: simplified procedure and increased specificity of method. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING THROMBOEMBOLISM COMPLICATIONS IN SURGICAL PATIENTS | 1997 |
|
RU2147230C1 |
| METHOD FOR DETERMINING FIBRINOLYTIC ACTIVITY OF URINE | 1998 |
|
RU2160448C2 |
| METHOD OF DIAGNOSIS HYPERFIBRINOLYSIS | 0 |
|
SU1675777A1 |
| METHOD OF SIMULATING DISSEMINATION INTRAVASCULAR BLOOD COAGULATION | 0 |
|
SU1336088A1 |
| METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY OF PATIENTS AFFECTED WITH ISCHEMIC HEART DISEASE | 1994 |
|
RU2082977C1 |
| DETERMINING OF CIRCULATING THROMBIN IN COMPLEMENT ACTIVATION TEST | 2019 |
|
RU2709341C1 |
| METHOD OF DETERMINING THROMBIN COMPLEMENTARITY SYSTEM ACTIVATION PATHWAY | 2019 |
|
RU2717946C1 |
| METHOD OF ANGIOPATHY DEVELOPMENT RISK DIAGNOSTICS IN ARTERIAL HYPERTENSION CASES WITH METABOLIC SYNDROME | 2007 |
|
RU2331883C1 |
| METHOD OF PRODUCING ANTICOAGULATIVE COLLAGENASE INHIBITOR FROM KING CRAB HEPATOPANCREAS | 2009 |
|
RU2403284C1 |
| METHOD OF DETERMINING ACTIVITY OF ANTITHROMBIN-III IN BLOOD PLASMA | 0 |
|
SU1508169A1 |
